BC

Birchview Capital Portfolio holdings

AUM $171M
1-Year Est. Return 85.36%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+85.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$171M
AUM Growth
+$38.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
80
New
Increased
Reduced
Closed

Top Buys

1
+$6.27M
2
+$3.52M
3
+$3.32M
4
BCYC
Bicycle Therapeutics
BCYC
+$2.28M
5
SLDB icon
Solid Biosciences
SLDB
+$2.22M

Top Sells

1
+$2.12M
2
+$1.91M
3
+$1.85M
4
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$1.16M
5
PRTA icon
Prothena Corp
PRTA
+$1.1M

Sector Composition

1 Healthcare 75.96%
2 Technology 19.61%
3 Energy 3.55%
4 Materials 0.54%
5 Financials 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KLAC icon
1
KLA
KLAC
$235B
$26.6M 15.57%
21,883
BMY icon
2
Bristol-Myers Squibb
BMY
$123B
$16.3M 9.56%
302,842
-14,000
CMPX icon
3
Compass Therapeutics
CMPX
$1.08B
$8.55M 5.01%
1,592,938
+720,000
STOK icon
4
Stoke Therapeutics
STOK
$2.2B
$8.25M 4.83%
260,000
+50,000
LRCX icon
5
Lam Research
LRCX
$334B
$6.9M 4.04%
+40,329
OLMA icon
6
Olema Pharmaceuticals
OLMA
$1.47B
$6.72M 3.94%
269,000
+95,000
GPCR icon
7
Structure Therapeutics
GPCR
$3.6B
$6.26M 3.66%
90,000
+12,000
PTGX icon
8
Protagonist Therapeutics
PTGX
$6.76B
$4.8M 2.81%
55,000
+7,000
ACAD icon
9
Acadia Pharmaceuticals
ACAD
$3.78B
$4.57M 2.67%
171,000
OVV icon
10
Ovintiv
OVV
$15B
$4.21M 2.47%
107,500
PRTA icon
11
Prothena Corp
PRTA
$587M
$4.21M 2.47%
441,019
-108,000
SLDB icon
12
Solid Biosciences
SLDB
$849M
$3.98M 2.33%
705,955
+409,000
NBIX icon
13
Neurocrine Biosciences
NBIX
$13.4B
$3.86M 2.26%
27,190
-1,500
FOLD icon
14
Amicus Therapeutics
FOLD
$4.54B
$3.6M 2.11%
253,000
BCYC
15
Bicycle Therapeutics
BCYC
$372M
$3.28M 1.92%
462,700
+308,700
PHAT icon
16
Phathom Pharmaceuticals
PHAT
$1.05B
$3.24M 1.89%
195,000
+110,000
CSTL icon
17
Castle Biosciences
CSTL
$759M
$3.14M 1.84%
80,600
-30,000
NTLA icon
18
Intellia Therapeutics
NTLA
$1.77B
$2.84M 1.66%
315,400
+255,400
IMNM icon
19
Immunome
IMNM
$2.79B
$2.79M 1.63%
130,000
+25,000
CORT icon
20
Corcept Therapeutics
CORT
$4.91B
$2.34M 1.37%
67,200
VERA icon
21
Vera Therapeutics
VERA
$3.03B
$2.23M 1.3%
+44,000
QDEL icon
22
QuidelOrtho
QDEL
$865M
$2.07M 1.21%
72,548
NVCR icon
23
NovoCure
NVCR
$1.46B
$1.97M 1.15%
152,100
+50,000
BDSX icon
24
Biodesix
BDSX
$133M
$1.95M 1.14%
286,804
CYTK icon
25
Cytokinetics
CYTK
$8.22B
$1.91M 1.12%
30,000
1
2 3 4